Related Articles
Alectinib Approved as Adjuvant Treatment for ALK-Positive Non–Small Cell Lung Cancer
On April 18, the U.S. Food and Drug Administration (FDA) approved the tyrosine kinase inhibitor alectinib (Alecensa) for adjuvant treatment after tumor resection in patients…
Improving Early Detection of Pancreatic Cancer in High-Risk Patients
Researchers have identified a novel screening strategy to improve early detection of pancreatic cancer in high-risk patients.
Natalie S. Callander, MD, on Multiple Myeloma: Management Updates
Natalie S. Callander, MD, of the University of Wisconsin Carbone Cancer Center, discusses advances in the treatment of patients with multiple myeloma, including her commentary…
Survival Rates in Patients With Cancer and Intellectual and Developmental Disabilities
Investigators have assessed the rate of survival in patients with intellectual and developmental disabilities diagnosed with breast cancer, colorectal cancer, or lung cancer.
Natalie S. Callander, MD, on Multiple Myeloma: Management Updates
Natalie S. Callander, MD, of the University of Wisconsin Carbone Cancer Center, discusses advances in the treatment of patients with multiple myeloma, including her commentary…
HER2-Positive Early Breast Cancer: PET-Based, pCR-Adapted Strategy
In the phase II PHERGain trial, researchers found that a positron-emission tomography (PET)-based, pathologic complete response (pCR)-adapted treatment strategy produced “excellent” 3-year invasive di…
Immunotherapy Resistance and Response to Adoptive Therapy in Patients With Metastatic Uveal Melanoma
A recent study explored the mechanisms behind conventional immunotherapy resistance as well as the efficacy of adoptive therapy in patients with metastatic uveal melanoma.
The Lancet Commission on Breast Cancer: Reducing Overlooked Inequities in Breast Cancer
Investigators have uncovered persistent inequities in breast cancer that may systematically leave many patients behind in spite of recent improvements in research, treatment, and survival,…
A Pioneering Female Oncologist in Morocco Helps Advance the Global Shift Toward Gender Equity in Academia
Success stories in research, advocacy, and education from low- and middle-income countries deserve international recognition to motivate the next generation of researchers and practitioners and…
Cisplatin, Gemcitabine, and IMRT in Locally Advanced Vulvar Cancer
Concurrent cisplatin, gemcitabine, and intensity-modulated radiation therapy (IMRT) produced a high rate of complete pathologic response in patients with locally advanced vulvar squamous cell carcinom…